Klocker H - Search Results

1

Glycoprofiling of proteins as prostate cancer biomarkers: A multinational population study.

Pinkeova A, Tomikova A, Bertokova A, Fabinyova E, Bartova R, Jane E, Hroncekova S, Sievert KD, Sokol R, Jirasko M, Kucera R, Eder IE, Horninger W, Klocker H, Ďubjaková P, Fillo J, Bertok T, Tkac J. Pinkeova A, et al. Among authors: klocker h. PLoS One. 2024 Mar 18;19(3):e0300430. doi: 10.1371/journal.pone.0300430. eCollection 2024. PLoS One. 2024. PMID: 38498504 Free PMC article.

2

Validating fPSA Glycoprofile as a Prostate Cancer Biomarker to Avoid Unnecessary Biopsies and Re-Biopsies.

Bertok T, Jane E, Bertokova A, Lorencova L, Zvara P, Smolkova B, Kucera R, Klocker H, Tkac J. Bertok T, et al. Among authors: klocker h. Cancers (Basel). 2020 Oct 15;12(10):2988. doi: 10.3390/cancers12102988. Cancers (Basel). 2020. PMID: 33076457 Free PMC article.

3

Targeting the androgen receptor in hormone-refractory prostate cancer--new concepts.

Eder IE, Haag P, Bartsch G, Klocker H. Eder IE, et al. Among authors: klocker h. Future Oncol. 2005 Feb;1(1):93-101. doi: 10.1517/14796694.1.1.91. Future Oncol. 2005. PMID: 16555979 Review.

4

Lovastatin causes diminished PSA secretion by inhibiting AR expression and function in LNCaP prostate cancer cells.

Yang L, Egger M, Plattner R, Klocker H, Eder IE. Yang L, et al. Among authors: klocker h. Urology. 2011 Jun;77(6):1508.e1-7. doi: 10.1016/j.urology.2010.12.074. Urology. 2011. PMID: 21624609

5

Age-Adjusted PSA Levels in Prostate Cancer Prediction: Updated Results of the Tyrol Prostate Cancer Early Detection Program.

Heidegger I, Fritz J, Klocker H, Pichler R, Bektic J, Horninger W. Heidegger I, et al. Among authors: klocker h. PLoS One. 2015 Jul 28;10(7):e0134134. doi: 10.1371/journal.pone.0134134. eCollection 2015. PLoS One. 2015. PMID: 26218594 Free PMC article.

6

Emerging promising biomarkers for treatment decision in metastatic castration-resistant prostate cancer.

Kafka M, Eder IE, Klocker H, Heidegger I. Kafka M, et al. Among authors: klocker h. Urol Oncol. 2020 Nov;38(11):801-815. doi: 10.1016/j.urolonc.2020.05.025. Epub 2020 Jun 24. Urol Oncol. 2020. PMID: 32591248 Review.

7

Enhanced antiproliferative and proapoptotic effects on prostate cancer cells by simultaneously inhibiting androgen receptor and cAMP-dependent protein kinase A.

Desiniotis A, Schäfer G, Klocker H, Eder IE. Desiniotis A, et al. Among authors: klocker h. Int J Cancer. 2010 Feb 1;126(3):775-89. doi: 10.1002/ijc.24806. Int J Cancer. 2010. PMID: 19653278 Free article.

8

In vitro model systems to study androgen receptor signaling in prostate cancer.

Sampson N, Neuwirt H, Puhr M, Klocker H, Eder IE. Sampson N, et al. Among authors: klocker h. Endocr Relat Cancer. 2013 Mar 26;20(2):R49-64. doi: 10.1530/ERC-12-0401. Print 2013 Apr. Endocr Relat Cancer. 2013. PMID: 23447570 Review.

9

Novel therapeutic approaches for the treatment of castration-resistant prostate cancer.

Heidegger I, Massoner P, Eder IE, Pircher A, Pichler R, Aigner F, Bektic J, Horninger W, Klocker H. Heidegger I, et al. Among authors: klocker h. J Steroid Biochem Mol Biol. 2013 Nov;138:248-56. doi: 10.1016/j.jsbmb.2013.06.002. Epub 2013 Jun 20. J Steroid Biochem Mol Biol. 2013. PMID: 23792785 Free PMC article. Review.

10

Genes differentially expressed in prostate cancer.

Eder IE, Bektic J, Haag P, Bartsch G, Klocker H. Eder IE, et al. Among authors: klocker h. BJU Int. 2004 May;93(8):1151-5. doi: 10.1111/j.1464-410X.2004.04869.x. BJU Int. 2004. PMID: 15142130 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

329 results

Search Page